This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taubert, H. Articles by Würl, P. Search for Related Content PubMed PubMed Citation Articles by Taubert, H. Articles by Würl, P.

Prognosis Is Correlated with p53 Mutation Type for Soft Tissue Sarcoma Patients¹

Institute of Pathology [H. T., A. M.] and Surgical Clinic [P. W.], Martin Luther University of Halle, Magdeburger Strasse 14, D-06097 Halle/Salle, Germany

We investigated the prognostic value of p53 mutation type for 145 soft tissue sarcoma patients. In a PCR-SSCP-sequencing analysis, 15 mutations were identified: 10 nonframeshift (non-fs) and 5 frameshift (fs) mutations. Patients possessing non-fs mutations had a significantly poorer prognosis than patients without p53 mutations (P = 0.014), according to Cox's multivariate analysis. In contrast, the survival of five patients with fs mutations was not affected by their mutation type. Furthermore, occurrence of lymph node metastases and recurrences was correlated with the mutation type; i.e., 4 of 10 and 5 of 10 patients with non-fs mutations showed lymph node metastases and recurrences, respectively, whereas none of the patients with fs mutations showed lymph node metastases and only one a recurrence. Therefore, for the evaluation of prognosis, we suggest applying not the p53 mutational status in general, but the specific type of mutation.

¹ This work was supported in part by Grant FKZ:01229105 from the Bundesministerium für Forschung und Technologie.

² To whom requests for reprints should be addressed. Phone: 49-345-557-1293; Fax: 49-345-557-1295; E-mail: mgopu@mlucom2.urz.uni-halle.de.

Received 6/13/96. Accepted 7/29/96.

This article has been cited by other articles:

				P. Lonning, S Knappskog, V Staalesen, R Chrisanthar, and J. Lillehaug Breast cancer prognostication and prediction in the postgenomic era Ann. Onc., August 1, 2007; 18(8): 1293 - 1306. [Abstract] [Full Text] [PDF]

				J Peltonen, J A Welsh, and K H Vahakangas Is there a role for PCR-SSCP among the methods for missense mutation detection of TP53 gene? Human and Experimental Toxicology, January 1, 2007; 26(1): 9 - 18. [Abstract] [PDF]

				R. Schneider-Stock, A. Ziegeler, C. Haeckel, D.-S. Franke, J. Rys, and A. Roessner Prognostic Relevance of p53 Alterations and Mib-1 Proliferation Index in Subgroups of Primary Liposarcomas Clin. Cancer Res., October 1, 1999; 5(10): 2830 - 2835. [Abstract] [Full Text] [PDF]

				D. F. Kusewitt, T. E. Sherburn, K. B. Miska, G. B. Tafoya, J. M. Gale, and R. D. Miller The p53 tumor suppressor gene of the marsupial Monodelphis domestica: cloning of exons 4–11 and mutations in exons 5–8 in ultraviolet radiation-induced corneal sarcomas Carcinogenesis, June 1, 1999; 20(6): 963 - 968. [Abstract] [Full Text] [PDF]